Erectile dysfunction is a strong predictor of death from all causes and of myocardial infarction, stroke, and heart failure in men with cardiovascular disease.
Dallas-Erectile dysfunction is a strong predictor of death from all causes and of myocardial infarction, stroke, and heart failure in men with cardiovascular disease, German researchers reported in Circulation: Journal of the American Heart Association (published online, March 15, 2010).
Researchers from the University of Saarland found that men with CVD and ED (compared to those without ED) were twice as likely to suffer death from all causes and 1.6 times more likely to suffer the composite of cardiovascular death, heart attack, stroke, and heart failure hospitalization. More specifically, they were 1.9 times more likely to die from cardiovascular disease, twice as likely to have a heart attack, 1.2 times more likely to be hospitalized for heart failure, and 1.1 times more likely to have a stroke.
The authors also found that, though ACE inhibitors, angiotensin receptor blockers, or a combination of the two can reduce CV events in high-risk patients, the drugs didn't influence the course nor the development of ED.
Deaths from all causes occurred in 11.3% of the patients who reported ED at baseline, but in only 5.6% of those with no or mild ED at the start of the study. The composite primary outcome of cardiovascular death, heart attack, stroke, and heart failure hospitalization occurred in 16.2% of ED patients compared to 10.3% of patients with no or mild ED.
Boehringer-Ingelheim, Germany funded the study.
From evidence to practice: Dr. Makarov discusses implementation science in urology
July 25th 2024“What our major contribution is, I think as urologists doing implementation science, is determining the important questions, which we are particularly well-suited to do because we're taking care of the patients,” says Danil V. Makarov, MD, MHS.
Phase 1B trial to evaluate relugolix and enzalutamide in high-risk prostate cancer
July 24th 2024"Going forward after this study, we hope to be able to expand and potentially look at patients undergoing either surgery or radiation therapy, and really try to determine the potential benefit," says Kelly L. Stratton, MD, FACS.